Photo from LinkedIn

AI-startup Fourth Paradigm plans to list on HKEX

The company’s cornerstone investors have subscribed to shares worth about US$96.8m.

Beijing Fourth Paradigm Technology plans to list its H Shares on Hong Kong Stock Exchange’s main board. It anticipates to raise $885.0m in net proceeds from the global offering.

The company intends to offer 18.4 million shares, with 90% being International Offer Shares and 10% as Hong Kong Offer Shares. It will have an offer price range of $55.60 to $61.16, per share, plus applicable fees.

The Hong Kong Public Offering will run from 18 September to 21 September. Trading of Fourth Paradigm shares on the Hong Kong Stock Exchange is expected to begin on 28 September, with board lots of 100 shares each.

ALSO READ: SG RNA tech firm completes $390m Series D funding; applies for HKEX

Key financial institutions involved in this offering include China International Capital Corporation Hong Kong Securities Limited as the Sole Sponsor and others as Joint Global Coordinators, Bookrunners, and Lead Managers. 

The company also has cornerstone investors who subscribed to shares worth approximately US$96.8m.

The funds accumulated will be allocated to enhance research, and technological capabilities, expand offerings, pursue strategic investments, and for general corporate purposes.

 

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Hong Kong Residency rule could boost office sector
The ultra-rich are also expected to set up family offices in the city.
Allegrow Biotech engineers technology to activate immune cells
The startup’s invention can be used to treat and potentially cure diseases like cancer.
Healthcare
Renminbi rise to fuel Bank of China HK’s growth
The lender expects the currency to be used more often in cross-border deals.
Retail Banking